Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The
Company’s common stock is listed for trading on the Nasdaq Capital Market stock exchange under the symbol BMRA. As of August 28, 2024, the number of holders of record of Biomerica’s common stock was approximately 850, excluding stock held in street
name. The number of record holders does not bear any relationship to the number of beneficial owners of the common stock as most of
the Company’s common stock is held in street name at securities brokerage firms.
The
Company has not paid any cash dividends on its common stock in the past and does not plan to pay any cash dividends on its common stock
in the foreseeable future. The Company intends, for the foreseeable future, to retain any earnings to finance the continued operation
and expansion of the Company’s business.
We
did not purchase any of our shares of common stock or other securities during our fiscal year ended May 31, 2024.
The
table below provides information relating to our equity compensation plans as of May 31, 2024:
Securities Plan Category
Number of Securities to be Issued Upon Exercise of Outstanding Options
Compensation Plans Weighted-Average Exercise Price of Outstanding Options
Securities Remaining Available for Future Issuance Under Compensation Plans
Equity Compensation Plans Approved by Securities Holders
3,479,616
$ 2.53
89,801
ITEM
6. RESERVED
Not
required.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.